<table class="drug-table data-table table table-condensed table-bordered"><tbody><tr id="identification"><th class="divider" colspan="2">Identification</th></tr><tr><th>Name</th><td><strong>Bacitracin</strong></td></tr><tr><th>Accession Number</th><td><strong>DB00626</strong>&#160; (APRD00816)</td></tr><tr><th>Type</th><td>small molecule</td></tr><tr><th>Groups</th><td>approved</td></tr><tr><th>Description</th><td><p>Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of Bacillus subtilis var Tracy. Its unique name derives from the fact that the bacillus producing it was first isolated in 1943 from a knee scrape from a girl named Margaret Tracy. As a toxic and difficult-to-use antibiotic, bacitracin doesn&#8217;t work well orally. However, it is very effective topically.</p>
<p>Bacitracin is synthesised via the so-called nonribosomal peptide synthetases (NRPSs), which means that ribosomes are not involved in its synthesis.</p></td></tr><tr><th>Structure</th><td><div class="structure"><a class="moldbi-thumbnail" href="http://structures.wishartlab.com/molecules/DB00626/image.png"><img alt="Thumb" src="http://structures.wishartlab.com/molecules/DB00626/thumb.png"></a></div><div class="structure-links"><div class="btn-group btn-group-xs"><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00626.mol">MOL</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00626.sdf">SDF</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00626.pdb">PDB</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00626.smiles">SMILES</a><a class="btn btn-default" href="/structures/structures/small_molecule_drugs/DB00626.inchi">InChI</a><a class="btn btn-info" href="/structures/structures/small_molecule_drugs/DB00626">View Structure</a></div></div></td></tr><tr><th>Synonyms</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Salts</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Brand names</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="brands"><thead><tr><th>Name</th><th>Company</th></tr></thead><tbody><tr><td>Baciguent</td><td>Upjohn</td></tr><tr><td>Baciim</td><td>X-Gen Pharmaceuticals, Inc.</td></tr></tbody></table></td></tr><tr><th>Brand mixtures</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="mixtures"><thead><tr><th>Brand Name</th><th>Ingredients</th></tr></thead><tbody><tr><td>AK-POLY-BAC</td><td>Bacitracin + Polymyxin B Sulfate</td></tr><tr><td>Antibiotic Ointment</td><td>Bacitracin + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Aurex Rotenone Drops</td><td>Bacitracin + Penicillin + Rotenone + Streptomycin (Streptomycin Sulfate) + Undecylenic Acid</td></tr><tr><td>Baciguent Plus Pain Reliever Ont</td><td>Bacitracin + Lidocaine</td></tr><tr><td>Bacitracin-Neomycin Polymyxin Ont</td><td>Bacitracin Zinc + Neomycin Sulfate + Polymyxin B Sulfate</td></tr><tr><td>Bacitracin-Neomycin-Polymixin Ont</td><td>Bacitracin Zinc + Neomycin Sulfate + Polymyxin B Sulfate</td></tr><tr><td>Bacitracin-Neomycin-Polymyxin Oph Ont</td><td>Bacitracin Zinc + Neomycin Sulfate + Polymyxin B Sulfate</td></tr><tr><td>Band-Aid-S-1</td><td>Bacitracin Zinc + Polymyxin B Sulfate</td></tr><tr><td>Emercreme No4 Ont Efa</td><td>Bacitracin + Benzocaine + Cetylpyridinium Chloride + Diphenylpyraline Hydrochloride + Tyrothricin</td></tr><tr><td>First Aid Antibiotic</td><td>Bacitracin Zinc + Polymyxin B Sulfate</td></tr><tr><td>First Aid Antibiotic Ointment</td><td>Bacitracin Zinc + Polymyxin B Sulfate</td></tr><tr><td>Gercillin</td><td>Bacitracin + Benzocaine + Polymyxin B Sulfate + Tyrothricin</td></tr><tr><td>Lanabiotic Ont</td><td>Bacitracin + Polymyxin B Sulfate</td></tr><tr><td>Mycitracin Oph Ont</td><td>Bacitracin + Neomycin Sulfate + Polymyxin B Sulfate</td></tr><tr><td>Neo Bace Ophthalmic Ointment</td><td>Bacitracin + Polymyxin B Sulfate</td></tr><tr><td>NEO-POLY-BAC</td><td>Bacitracin + Polymyxin B Sulfate + Neomycin</td></tr><tr><td>NEO-POLYCIN</td><td>Bacitracin + Hydrocortisone + Polymyxin B Sulfate + Neomycin</td></tr><tr><td>Neosporin Ointment</td><td>Bacitracin (Bacitracin Zinc) + Neomycin (Neomycin Sulfate) + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Neosporin Ophthalmic Ointment</td><td>Bacitracin (Bacitracin Zinc) + Neomycin (Neomycin Sulfate) + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Neotopic Ointment</td><td>Bacitracin (Bacitracin Zinc) + Neomycin (Neomycin Sulfate) + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Ozonol Antibiotic Plus - Ointment</td><td>Bacitracin + Lidocaine Hydrochloride + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Ozonol Antibiotic Plus Ont</td><td>Bacitracin + Lidocaine Hydrochloride + Polymyxin B Sulfate</td></tr><tr><td>Polycidin Ophthalmic Ointment</td><td>Bacitracin (Bacitracin Zinc) + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>POLYCIN</td><td>Bacitracin + Polymyxin B Sulfate</td></tr><tr><td>Polyderm Antibiotic Ointment</td><td>Bacitracin + Lidocaine Hydrochloride + Polymyxin B Sulfate</td></tr><tr><td>Polysporin Antibiotic Ointment</td><td>Bacitracin + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Polysporin Sterile Ophthalmic Ointment</td><td>Bacitracin (Bacitracin Zinc) + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Polysporin Topical First Aid Antibiotic Ointment</td><td>Bacitracin + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Polysporin Triple Antibiotic Ointment</td><td>Bacitracin + Gramicidin + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Polytopic Ont</td><td>Bacitracin + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Polytracin Ont</td><td>Bacitracin Zinc + Polymyxin B (Polymyxin B Sulfate)</td></tr><tr><td>Sandoz Cortimyxin</td><td>Bacitracin (Bacitracin Zinc) + Hydrocortisone + Neomycin (Neomycin Sulfate) + Polymyxin B (Polymyxin B Sulfate)</td></tr></tbody></table></td></tr><tr><th>Categories</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>CAS number</th><td>1405-87-4</td></tr><tr><th>Weight</th><td>Average: 1422.693<br>Monoisotopic: 1421.748941023</td></tr><tr><th>Chemical Formula</th><td>C<sub>66</sub>H<sub>103</sub>N<sub>17</sub>O<sub>16</sub>S</td></tr><tr><th>InChI Key</th><td>CLKOFPXJLQSYAH-ABRJDSQDSA-N</td></tr><tr><th>InChI</th><td><div class="wrap">InChI=1S/C66H103N17O16S/c1-9-35(6)52(69)66-81-48(32-100-66)63(97)76-43(26-34(4)5)59(93)74-42(22-23-50(85)86)58(92)83-53(36(7)10-2)64(98)75-40-20-15-16-25-71-55(89)46(29-49(68)84)78-62(96)47(30-51(87)88)79-61(95)45(28-39-31-70-33-72-39)77-60(94)44(27-38-18-13-12-14-19-38)80-65(99)54(37(8)11-3)82-57(91)41(21-17-24-67)73-56(40)90/h12-14,18-19,31,33-37,40-48,52-54H,9-11,15-17,20-30,32,67,69H2,1-8H3,(H2,68,84)(H,70,72)(H,71,89)(H,73,90)(H,74,93)(H,75,98)(H,76,97)(H,77,94)(H,78,96)(H,79,95)(H,80,99)(H,82,91)(H,83,92)(H,85,86)(H,87,88)/t35-,36-,37-,40-,41+,42+,43-,44+,45-,46-,47+,48-,52-,53-,54-/m0/s1</div></td></tr><tr><th>IUPAC Name</th><td><div class="wrap">(4R)-4-[(2S)-2-{[(4R)-2-[(1S,2S)-1-amino-2-methylbutyl]-4,5-dihydro-1,3-thiazol-4-yl]formamido}-4-methylpentanamido]-4-{[(1S,2S)-1-{[(3S,6R,9S,12R,15S,18R,21S)-18-(3-aminopropyl)-12-benzyl-15-[(2S)-butan-2-yl]-3-(carbamoylmethyl)-6-(carboxymethyl)-9-(1H-imidazol-4-ylmethyl)-2,5,8,11,14,17,20-heptaoxo-1,4,7,10,13,16,19-heptaazacyclopentacosan-21-yl]carbamoyl}-2-methylbutyl]carbamoyl}butanoic acid</div></td></tr><tr><th>SMILES</th><td><div class="wrap">CC[C@H](C)[C@H](N)C1=N[C@@H](CS1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H]1CCCCNC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](CC(O)=O)NC(=O)[C@H](CC2=CNC=N2)NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)[C@@H](NC(=O)[C@@H](CCCN)NC1=O)[C@@H](C)CC</div></td></tr><tr><th>Mass Spec</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="taxonomy"><th class="divider" colspan="2">Taxonomy</th></tr><tr><th>Kingdom</th><td>Organic Compounds</td></tr><tr><th>Superclass</th><td>Organic Acids and Derivatives</td></tr><tr><th>Class</th><td>Carboxylic Acids and Derivatives</td></tr><tr><th>Subclass</th><td>Amino Acids, Peptides, and Analogues</td></tr><tr><th>Direct parent</th><td>Peptidomimetics</td></tr><tr><th>Alternative parents</th><td>N-acyl-alpha Amino Acids and Derivatives; Alpha Amino Acid Amides; Thiazolecarboxamides; Imidazolyl Carboxylic Acids and Derivatives; Dicarboxylic Acids and Derivatives; Benzene and Substituted Derivatives; Thiazolines; Polyols; Imidothioesters; Primary Carboxylic Acid Amides; Secondary Carboxylic Acid Amides; Polyamines; Carboxylic Acids; Enolates; Monoalkylamines</td></tr><tr><th>Substituents</th><td>n-acyl-alpha amino acid or derivative; alpha-amino acid amide; alpha-amino acid or derivative; thiazolecarboxamide; imidazolyl carboxylic acid derivative; benzene; dicarboxylic acid derivative; meta-thiazoline; azole; imidazole; thiazole; polyol; carboxamide group; imidothioester; secondary carboxylic acid amide; primary carboxylic acid amide; polyamine; carboxylic acid; enolate; primary amine; amine; alcohol; primary aliphatic amine; organonitrogen compound</td></tr><tr><th>Classification description</th><td>This compound belongs to the peptidomimetics. These are compounds containing non-peptidic structural elements that is capable of mimicking or antagonizing the biological action(s) of a natural parent peptide.</td></tr><tr id="pharmacology"><th class="divider" colspan="2">Pharmacology</th></tr><tr><th>Indication</th><td>For the treatment of infants with pneumonia and empyema caused by staphylococci shown to be susceptible to the drug. Also used in ointment form for topical treatment of a variety of localized skin and eye infections, as well as for the prevention of wound infections. Used against gram positive bacteria. Bacitracin is also used as an inhibitor of proteases and other enzymes. 
However, specific activity of bactracin's inhibition of protein disulfide isomerase has been called into question. </td></tr><tr><th>Pharmacodynamics</th><td>Bacitracin is a mixture of related cyclic polypeptides produced by organisms of the licheniformis group of <i>Bacillus subtilis var</i> Tracy. As a polypeptide, toxic, and difficult to use chemical, bacitracin doesn't work well orally, however is very effective topically. Bacitracin exerts pronounced antibacterial action in vitro against a variety of gram-positive and a few gram-negative organisms. However, among systemic diseases, only staphylococcal infections qualify for consideration of bacitracin therapy. </td></tr><tr><th>Mechanism of action</th><td>Bacitracin intereferes with the dephosphorylation of the 55-carbon, biphosphate lipid transport molecule C55-isoprenyl pyrophosphate (undecaprenyl pyrophosphate), which carries the building blocks of the peptidoglycan bacterial cell wall outside the inner membrane for construction. Bacitracin binds divalent transition metal ions (Mn(II), Co(II), Ni(II), Cu(II), and Zn(II)) which binds and oxidatively cleave DNA. </td></tr><tr><th>Absorption</th><td>Absorption of bacitracin following intramuscular injection is rapid and complete. Absorption from the gastrointestinal tract following oral administration is not appreciable. Absorption following topical application is negligible.</td></tr><tr><th>Volume of distribution</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Protein binding</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Metabolism</th><td class="data-table-container"></td></tr><tr><th>Route of elimination</th><td>The drug is excreted slowly by glomerular filtration.</td></tr><tr><th>Half life</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Clearance</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>Toxicity</th><td>Oral, mouse: LD<sub>50</sub> = &gt;3750 mg/kg.</td></tr><tr><th>Affected organisms</th><td><ul><li>Enteric bacteria and other eubacteria</li></ul></td></tr><tr><th>Pathways</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Effects</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr><th>SNP Mediated Adverse Drug Reactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="admet"><th class="divider" colspan="2">ADMET</th></tr><tr><th>Predicted ADMET features</th><td class="data-table-container"><table class="table table-condensed table-striped" id="predicted-admet">
  <thead>
    <tr>
      <th>Property</th>
      <th>Value</th>
      <th>Probability</th>
    </tr>
  </thead>
  <tbody>
      <tr>
        <td>Human Intestinal Absorption</td>
        <td>
              -
        </td>
        <td>0.7857</td>
      </tr>
      <tr>
        <td>Blood Brain Barrier</td>
        <td>
              -
        </td>
        <td>0.9943</td>
      </tr>
      <tr>
        <td>Caco-2 permeable</td>
        <td>
              -
        </td>
        <td>0.7639</td>
      </tr>
      <tr>
        <td>P-glycoprotein substrate</td>
        <td>
            Substrate
        </td>
        <td>0.7416</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor I</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.898</td>
      </tr>
      <tr>
        <td>P-glycoprotein inhibitor II</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9697</td>
      </tr>
      <tr>
        <td>Renal organic cation transporter</td>
        <td>
            Non-inhibitor
        </td>
        <td>0.9073</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-substrate</td>
        <td>0.7482</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-substrate</td>
        <td>0.7884</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-substrate</td>
        <td>0.5435</td>
      </tr>
      <tr>
        <td>CYP450 1A2 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9046</td>
      </tr>
      <tr>
        <td>CYP450 2C9 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9071</td>
      </tr>
      <tr>
        <td>CYP450 2D6 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9231</td>
      </tr>
      <tr>
        <td>CYP450 2C19 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9025</td>
      </tr>
      <tr>
        <td>CYP450 3A4 substrate</td>
        <td>Non-inhibitor</td>
        <td>0.9011</td>
      </tr>
      <tr>
        <td>CYP450 inhibitory promiscuity</td>
        <td>Low CYP Inhibitory Promiscuity</td>
        <td>0.9122</td>
      </tr>
      <tr>
        <td>Ames test</td>
        <td>
          Non AMES toxic 
        </td>
        <td>
            0.7225
        </td>
      </tr>
      <tr>
        <td>Carcinogenicity</td>
        <td>
          Non-carcinogens 
        </td>
        <td>
            0.9045
        </td>
      </tr>
      <tr>
        <td>Biodegradation</td>
        <td>
          Not ready biodegradable 
        </td>
        <td>
            0.9799
        </td>
      </tr>
      <tr>
        <td>Rat acute toxicity</td>
        <td>
          2.8201 
            LD50, mol/kg
        </td>
        <td>
            <span class="wishart wishart-not-available">Not applicable</span>
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor I)</td>
        <td>
          Weak inhibitor 
        </td>
        <td>
            0.9936
        </td>
      </tr>
      <tr>
        <td>hERG inhibition (predictor II)</td>
        <td>
          Non-inhibitor 
        </td>
        <td>
            0.6586
        </td>
      </tr>
  </tbody>
</table>
</td></tr><tr id="pharmacoeconomics"><th class="divider" colspan="2">Pharmacoeconomics</th></tr><tr><th>Manufacturers</th><td><ul><li>X gen pharmaceuticals inc</li>
<li>App pharmaceuticals llc</li>
<li>Pfizer laboratories div pfizer inc</li>
<li>Pharmacia and upjohn co</li>
<li>Sagent pharmaceuticals inc</li>
<li>Altana inc</li>
<li>Eli lilly and co</li>
<li>Pharmaderm div altana inc</li>
<li>Pharmafair inc</li>
<li>Combe inc</li>
<li>Naska pharmacal co inc div rugby darby group cosmetics</li>
<li>Apothekernes laboratorium a/s</li>
<li>Paddock laboratories inc</li></ul></td></tr><tr><th>Packagers</th><td><ul><li>Amend</li>
<li><a href="http://www.apppharma.com">APP Pharmaceuticals</a></li>
<li><a href="http://www.benvenue.com">Ben Venue Laboratories Inc.</a></li>
<li><a href="http://www.cvs.com">CVS Pharmacy</a></li>
<li><a href="http://www.drxdispensing.com">Dispensing Solutions</a></li>
<li><a href="http://www.dsm.com">DSM Corp.</a></li>
<li><a href="http://www.fougera.com">E. Fougera and Co.</a></li>
<li><a href="http://www.ferapharma.com">Fera Pharmaceuticals</a></li>
<li>Ivax Pharmaceuticals</li>
<li><a href="http://www.mckesson.com">Mckesson Corp.</a></li>
<li><a href="http://www.pharmaciaupjohn.com">Pharmacia Inc.</a></li>
<li><a href="http://www.physicianstotalcare.com">Physicians Total Care Inc.</a></li>
<li><a href="http://www.preferredpharmaceuticals.com">Preferred Pharmaceuticals Inc.</a></li>
<li>Redpharm Drug</li>
<li><a href="http://www.toku-e.com">Toku E Company</a></li>
<li><a href="http://www.x-gen.us">X-Gen Pharmaceuticals</a></li></ul></td></tr><tr><th>Dosage forms</th><td class="data-table-container"><table class="table table-condensed table-striped datatable" id="dosages"><thead><tr><th>Form</th><th>Route</th><th>Strength</th></tr></thead><tbody><tr><td>Ointment</td><td>Topical</td><td></td></tr><tr><td>Powder, for solution</td><td>Intramuscular</td><td></td></tr></tbody></table></td></tr><tr id="spectra"><th class="divider" colspan="2">Spectra</th></tr><tr><th>Spectra</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr><tr id="interactions"><th class="divider" colspan="2">Interactions</th></tr><tr><th>Drug Interactions</th><td>Searched, but no interactions found.</td></tr><tr><th>Food Interactions</th><td><span class="wishart wishart-not-available">Not Available</span></td></tr></tbody></table>